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Abstract 
Denervation leads to the activation of the catabolic pathways, such as the ubiquitin-proteasome 
and autophagy, resulting in skeletal muscle atrophy and weakness. Furthermore, denervation 
induces oxidative stress in skeletal muscle, which is thought to contribute to the induction of 
skeletal muscle atrophy. Several muscle diseases are characterized by denervation, but the 
molecular pathways contributing to muscle atrophy have been only partially described. Our 
study delineates the kinetics of activation of oxidative stress response in skeletal muscle 
following denervation. Despite the denervation-dependent induction of oxidative stress in 
skeletal muscle, treatments with anti-oxidant drugs do not prevent the reduction of muscle 
mass. Our results indicate that, although oxidative stress may contribute to the activation of the 
response to denervation, it is not responsible by itself of oxidative damage or neurogenic 
muscle atrophy. 
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 Loss of motoneuron innervation severely 
compromises skeletal muscle mass and function. 
Neurogenic atrophy is caused by peripheral 
neuropathies or motor neuron diseases. Muscle atrophy 
results from increasing catabolism of skeletal muscle 
proteins often coupled with reduced rates of protein 
synthesis.
1
 Oxidative stress (OS) has been implicated in 
many pathological conditions, including sarcopenia
2
, 
unloading
3
 Amyotrophic lateral sclerosis,
4
 and is now 
widely considered a major trigger of the imbalance 
between protein synthesis and degradation.
5,6
 How is 
OS thought to contribute to muscle atrophy? On one 
hand ROS directly or indirectly damage mitochondria 
and cellular components, triggering autophagy, one of 
the main catabolic pathway.
7
 Changes in mitochondrial 
shape also activate AMPK, which in turn positively 
regulates FoxO3,
8,9
 leading to muscle atrophy via the 
autophagic and ubiquitin-proteasome system. Together 
with an increase in muscle proteolysis, muscle atrophy 
is the result of decreased regenerative ability. OS and 
impaired antioxidant activity negatively affect the 
differentiation of satellite cells,
2,10
 the muscle progenitor 
cells, responsible for the repair or growth of adult 
skeletal muscle. Since excessive OS contributes to 
muscle damage, a proper response is critical to maintain 
cell homeostasis. Several transcription factors are 
activated in response to OS and can trigger either cell 
protection or cell death, depending on ROS levels. 
Intracellular oxidative stress is sensed by NF-E2 p45-
related factor 2 (Nfe2L2), a transcription factor which 
induces the expression of phase II antioxidant genes.
11,12
 
Antioxidant enzymes regulated by Nfe2L2 include: 
heme oxygenase-1 (Hmox1), NAD(P)H:quinone 
oxidoreductase (Nqo1), thioredoxin reductase 1 (Txn 1), 
glutamate-cysteine ligase modifier subunit (Gclm) and 
glutamate-cysteine ligase catalytic subunit (Gclc).
12-14
 
Increased levels of ROS can also be sensed by NFκB. 
NFκB has a dual role in the OS response because, on 
one hand, NFκB activates several genes that play a 
major role in antioxidant defense (e.g. manganese 
superoxide dismutase - MnSOD, Nqo1, glutathione 
oxidoreductase-1 - Gpx1), on the other hand, other 
NFκB-targets are involved in ROS generation (e.g. 
NADPH oxidase 2 – Cybb, inducible nitric oxide 
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synthase – iNOS, cyclooxygenase-2 – Cox2) and 
skeletal muscle atrophy (MuRF1). Moreover, a cross 
talk between Nfe2L2 and NFκB has been demonstrated 
in several experimental models. Indeed, as redox-
sensitive transcription factors, depending on the levels 
of ROS, Nfe2L2 and NFκB are activated, coordinating 
distinct biological responses.
11,12,15,16
 An increase in 
mitochondrial-derived reactive oxygen species (ROS) 
has been reported following denervation, correlating 
with a decrease in mitochondrial respiration rate,
17
 but 
its biological relevance has not been addressed yet. 
The aim of the present study is to delineate the kinetics 
of activation of OS and OS-response in murine skeletal 
muscle following denervation, and to assess the 
contribution of OS to neurogenic muscle atrophy in 
vivo. 
Material and Methods 
Ethical Approval 
Mice were treated in strict accordance with the 
guidelines of the Institutional Animal Care and Use 
Committee and to national and European legislation, 
throughout the experiments (Permit number 80/2014-B 
of 03/06/2014). Adult (2.5 month-old) C57BL/6 female 
mice were used throughout the experiments.  
Denervation 
Adult mice were anesthetized, and a 3 mm segment of  
the left limb sciatic nerve was excised. The non-
denervated contralateral limb was used as control.  
When antioxidants were administered, mice were 
treated daily, starting from the day of denervation, by an 
intraperitoneal (i.p.) injection of 15 mg/kg Trolox 
(Sigma) in 40% NaOH in physiologic solution, or 50 
mg/kg Resveratrol (Sigma) in 1% EtOH in physiologic 
solution. Vehicle-treated animals were used as controls. 
Histological Analyses 
Tibialis Anterior (TA) muscles were dissected, 
embedded in tissue freezing medium (Leica, Wetzlar, 
Germany) and frozen in liquid nitrogen pre-cooled 
isopentane. Cryosections (8 μm) were obtained by using 
a Leica cryostat. Dihydrohetidium (DHE) staining was 
performed on transverse cryosections of TA muscles. 
Unfixed cryosections were incubated with 0,002 mM 
DHE (Molecular Probes D1168) in DMSO for 30 
minutes at 37° C. Coverslips were mounted with 60% 
glycerol in Tris HCl 0.2M pH 9.3. DHE intensity was 
quantified by measuring the signal in 10 fields for each 
sample, using image J software. Hematoxylin and eosin 
staining was performed according to the Sigma 
manufacturer’s instructions. For immunofluorescences, 
TA cryosections were fixed in 4% paraformaldehyde, 
then permeabilized with 0,2% triton (Sigma) in 
phosphate-buffered saline (PBS) and blocked with 10% 
BSA (Sigma) in PBS. Samples were then incubated 
with 1:50 dilution of Nfe2L2 (Santa Cruz (C-20) sc-
722), followed by incubation with 1:500 dilution of 
Alexa Fluor® 488 conjugate Secondary Antibody (A-
11008). Hoechst 33342 (Sigma) was used to stain 
nuclei. 
RNA Extraction and Real-time PCR 
Total RNA was isolated and purified from 30-50 mg of 
TA muscles by using Trizol (Invitrogen), following the 
manufacturer's protocol. One microgram of total RNA 
was converted to cDNA by using the QuantiTect 
Reverse Transcription Kit (Qiagen). Real-time PCR was 
performed with the SDS-ABI Prism 7500 (Applied 
Biosystem), by using the Sybr Green reaction mix 
(Applied Biosystem). Primers are listed in Table 1. 
RNA Extraction and Real-time PCR 
Total RNA was isolated and purified from 30-50 mg of 
TA muscles by using Trizol (Invitrogen), following the 
manufacturer's protocol. One microgram of total RNA 
was converted to cDNA by using the QuantiTect 
Reverse Transcription Kit (Qiagen). Real-time PCR was 
performed with the SDS-ABI Prism 7500 (Applied 
Biosystem), by using the Sybr Green reaction mix 
(Applied Biosystem). Primers are listed in Table 1. 
Protein Extraction and Western Blot Analyses 
TA muscles were dissected, minced, and homogenized 
in lysis buffer (50 mM Tris-HCl pH 7.4, 1 mM EDTA, 
150 Mm NaCl, 1% TRITON) supplemented with 
Table 1.  Table 1. List of the Primers used in Real-time PCR 
 
Gene Forward Reverse 
Cybb TCCTATGTTCCTGTACCTTTGTG GTCCCACCTCCATCTTGAATC 
Nfe2L2 TTGGCAGAGACATTCCCATTTG AAACTTGCTCCATGTCCTGCTCTA 
Gclc GGCGATGTTCTTGAGACTCTGC TTCCTTCGATCATGTAACTCCC 
Gclm CACAGGTAAAACCCAATAGTAACCAAGT GTGAGTCAGTAGCTGTATGTCAAATTGTT 
Cybb TCCTATGTTCCTGTACCTTTGTG GTCCCACCTCCATCTTGAATC 
Hmox1 AGCCCCACCAAGTTCAAACA GCAGTATCTTGCACCA 
Nqo1 CATTCTGAAAGGCTGGTTTGA CTAGCTTTGATCTGGTTGTCA G 
Nfe2L2 TTGGCAGAGACATTCCCATTTG AAACTTGCTCCATGTCCTGCTCTA 
Cat TGAGAAGCCTAAGAACGCAAT CCCTTCGCABGCCATGTG 
Txn 1 GTCGTGGTGGACTTCTCTGCTA TTGTCACAGAGGGAATGGAAGA 
gapdh ACCCAGAAGACTGTGGATGG CACATTGGGGGTAGGAACAC 
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protease and phosphatase inhibitors (complete Mini 
EDTA-free and PhosSTOP, ROCHE). Proteins (30-50 
micrograms) were separated by SDS-PAGE and 
transferred to PVDF membrane (Invitrogen). Unspecific 
binding was blocked in 5% not fat dry milk in TBST 
buffer (20 mM Tris HCl pH 7.6, 137 mM NaCl, 0.5% 
Tween 20). The membranes were incubated overnight, 
with the appropriate primary antibody diluted in 5% 
BSA (Sigma) in TBST. After washing in TBST, 
membranes were incubated with secondary antibodies 
HRP-conjugate (Bio-Rad 170-6515 or 170-6516) and 
signals were detected by using ECL chemistry 
(Advansta). Images were aquired using films or 
ChemiDoc MP imaging system (Bio-Rad). 
Densitometric analyses were performed by measuring 
band intensity for each sample using Image J software.  
The following primary antibodies were used: Gapdh 
(Santa Cruz sc-32233), Cybb (BD bioscience 611414), 
P-Rela (Cell Signalling 3033), TOT-Rela (Cell 
Signalling 4764), 4-HNE (Abcam 46545) 
Antioxidant Enzymes Activities 
Muscles were homogenized in 100 mM Na-phosphate 
buffer pH 7.0 or pH 6.5 depending on the assay, with 
protease inhibitors cocktail (Sigma) and centrifuged at 
100,000 x g for 15 minutes at 4° C. Cytosol proteins 
were measured on the resulting supernatant according to 
the Bradford’s method. Glutathione S-transferase 
activity was determined by using 1-cloro-2-4-
dinitrobenzene (CDNB) as substrate. The assay was 
performed at 340 410 nm (ε = 9.6 mM-1 cm-1) in a final 
volume of 1 ml containing 100 mM Na-phosphate 
buffer pH 6.5, 1 mM CDNB, 1 mM reduced 
glutathione, and 50 µg of protein lysate. Glutathione 
reductase activity was measured by the rate of decrease 
in absorbance induced by NADPH oxidation, at 340 nm 
(ε = - 6.22 mM-1 cm-1). The assay mixture contained, in 
a final volume of 1 ml, 100 mM Na-phosphate buffer 
pH 7.0, 1 mM glutathione disulfide, 60 µM NADPH 
and 100 mg of protein lysate. 
Protein Carbonyl Assay 
The assay was performed as described in.
18
 The amount 
of protein-hydrozone produced is quantified 
spectrophotometrically. Carbonyl content was 
normalized to protein concentration 
Statistics 
Statistical significance was determined using two-tailed 
Student t-test with a significance level < 0.05 
Results 
Oxidative Stress is Induced in Skeletal Muscle 
Following Denervation 
In order to characterize the molecular pathways 
triggered by denervation in skeletal muscle, we severed 
the sciatic nerve of one limb of adult mice and analyzed 
the skeletal muscle response over time. To reduce the 
number of mice, we first tested if contralateral 
innervated muscles could be used as control. Oxidative 
stress was evaluated by measuring the ROS levels by 
Dihydrohetidium (DHE) staining and the expression 
levels of cytochrome b-245, beta polypeptide (Cybb) in 
the contralateral TA muscles, compared with control 
mice, not subjected to denervation. No significant 
differences were observed between the two groups (Fig. 
1), allowing contralateral muscles to be used as control 
muscles, thus reducing the number of experimental 
animals 
To assess if denervation induces OS in skeletal muscle, 
ROS were labeled by DHE in contralateral and in 
denervated muscles. Denervated muscles showed a 
time-dependent increase in ROS levels, compared to 
contralateral muscles (Fig. 2A). This result was 
confirmed by the kinetic of induction of Cybb 
expression, at both the mRNA and protein levels, (Fig. 
2B and C). OS activates NFκB which, in turn, regulates 
the expression of Cybb. To evaluate if denervation 
induces NFκB activation, the levels of the 
phosphorylated, active form of the Rela subunit (P-
Rela) of NFκB were monitored in TA muscles, over 
 
Fig 1. Oxidative stress is not induced in non-denervated, contralateral muscles. (A) DHE staining in TA of mice not subjected 
to denervation (control) or contralateral muscles of denervated mice (contra), 3 and 7 days following denervation. Scale 
bar = 50 μm. (B) Real-time PCR of Cybb in control and contralateral muscles, 3 and 7 days following denervation. 
Values represent mean ± SEM.  n = 3. 
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time. NFκB activation was detected as early as three 
days following denervation, and it further increased 
seven days after denervation (Fig. 2D). 
Since NFκB cross-talks with the Nfe2L2, we monitored 
Nfe2L2 activation in skeletal muscle upon denervation. 
Real-time PCR analyses showed increased levels of 
Nfe2L2 expression at three and seven days following 
denervation (Fig. 2E). Importantly, Nfe2L2 mainly 
 
 
Fig 2. Oxidative stress is induced in skeletal muscle following denervation. (A) DHE staining and quantification in innervated 
(contra) or denervated TA muscles, 3 and 7 days following denervation. Scale bar = 50 μm. Values represent mean ± SEM. n 
= 4. ***p<0.0001.  (B) Real-time PCR for Cybb at different time points following denervation, relative to innervated 
contralateral muscles. Values represent mean ± SEM. n = 4-6. *p<0.05; **p<0.001 vs contralateral muscles. (C) Western 
blotting analyses and densitometry of Cybb at indicated time points following denervation. Gapdh was used as loading 
control. n = 2-4; *p<0.05. (D) Western blot analyses and densitometry of P- and total Rela subunit of NFκB in TA muscles at 
the indicated time points following denervation. Gapdh was used as loading control. n = 2-4; *p<0.05. (E) Real-time PCR for 
Nfe2L2 in TA muscles at indicated time points following denervation, respect to contralateral muscles. Values represent 
mean ± SEM. n = 4-6. * p<0.05; ** p<0.001 vs contra muscles. (F) Immunofluorescence staining and quantification of 
intracellular localization of Nfe2L2 in skeletal muscle following denervation. Scale bar = 20 m. Values represent mean ± 
SEM. n = 2 each time point. * p<0.05. (G) Real-time PCR of Gclc and Gclm at indicated time points following denervation. 
Values represent mean ± SEM. n = 4-6. * p<0.05; ** p<0.001 vs contra muscles. (H) Enzymatic activities of Gsr and Gstp1 
at indicated time points following denervation, relative to contralateral muscles. n = 4. Values represent mean ± SEM 
*p<0.05 vs contra muscles. (I) Real-time PCR of indicated genesat indicated time points following denervation, relative to 
contralateral muscles. Values represent mean ± SEM. n = 4-6. *p<0.05; **p<0.001 vs contra muscles. 
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translocated into the nuclei at three and, even more, at 
seven days following denervation, compared to 
contralateral muscles (Fig. 2F). To confirm the kinetics 
of Nfe2L2 activation, we evaluated the expression of 
glutamate-cysteine ligase catalytic (Gclc) and modifier 
(Gclm) subunits, two known Nfe2L2 target genes
14
 (Fig. 
2G). The expression of both genes increased over time 
following denervation, confirming that Nfe2L2 is more 
active at seven than at three days following denervation. 
Glutathione plays a key role in cellular detoxification 
processes
19
 through glutathione reductase (Gsr) and 
glutathione S-transferase pi 1 (Gstp1) enzymes. Gsr 
activity was significantly increased at seven days, but it 
decreased at ten and fourteen days after denervation; 
conversely, Gstp1 achieved its maximal activity ten 
days following denervation (Fig. 2H). 
To determine the molecular response of skeletal muscle 
to OS, we monitored the expression of several genes 
involved in ROS buffering, over time. A significant 
induction of Hmox1 expression was detected as soon as 
eight hours following denervation reached the maximal 
expression at one day and decreased after three days. 
Expression of Nqo1 gene increased in a time-dependent 
manner, beginning at day three. The expression of other 
genes – i.e. catalase (Cat) and thioredoxin 1(Txn 1) – 
showed a significant induction one day following 
denervation, reached a peak after three days and 
decreased seven days after denervation (Fig. 2H). 
The effects of ROS are dose-dependent since they can 
act as physiological signaling molecules at low levels 
but they can be harmful above a threshold.
20
 To verify if 
the induction of OS upon denervation leads to muscle 
damage, protein carbonyl level and lipid peroxidation, 
sensitive biomarkers of ROS-mediated damage, were 
quantified in skeletal muscle tissue, seven days 
following denervation. Interestingly, denervation 
induced neither a significant increase in carbonyl groups 
nor an induction in lipid peroxidation (Fig. 3), as 
detected by 4-Hydroxynonenal (4-HNE) levels, 
suggesting that skeletal muscle is not damaged by OS 
after severing nerve. 
Oxidative Stress Does not Induce Muscle Atrophy 
Following Denervation 
Denervation induces skeletal muscle atrophy and OS. 
To investigate the contribution of OS to neurogenic 
muscle atrophy, mice were treated with Trolox, a cell-
permeable derivate of vitamin E with antioxidant 
properties,
21,22
 or vehicle as a control, starting from the 
day of denervation. We first verified that Trolox 
treatment effectively reduced OS in skeletal muscle 
following denervation, by evaluating cybb levels by 
Western blot analyses (Fig. 4A). Muscle mass 
evaluation and histological analyses showed that Trolox 
exerted no protective effects on muscle atrophy, two 
and four weeks following denervation (Fig. 4B & 4C). 
Similar results were obtain by treating mice with 
another anti-oxidant drug, Resveratrol,
23
 for four weeks 
following denervation (data not shown). These results 
indicate that denervation activates OS, which is 
however not responsible for neurogenic muscle atrophy. 
Discussion 
In this study, we examined the kinetics of activation of 
the OS response following denervation in skeletal 
muscle, and determined if ROS activation plays a causal 
role in the causing muscle atrophy. We showed that OS 
is induced in skeletal muscle as early as three days 
following denervation, prior to the appearance of 
muscle atrophy. Consistently, the induction of 
antioxidant response genes began at day three and 
increased over time following denervation, as confirmed 
by nuclear translocation of Nfe2L2 and by the kinetics 
of expression of Gclc and Gclm genes, two Nfe2L2 
targets. It has been reported that muscle inactivity or 
denervation increases the levels of ROS as a 
consequence of both reduced antioxidant capacity and 
induced production of ROS.
24-26
 Furthermore, exercise 
and Functional Electrical Stimulation (FES) greatly 
improve muscle mass and functionality in denervated 
patients;
27,28
 although, a direct correlation between 
treatment and improved antioxidant defense has 
established  only for physical activity, while FES 
stimulus is insufficient to change oxidative status on 
denervated muscles.
29,30
 Here we showed that the 
expression of antioxidant genes increased quickly 
following denervation, suggesting that OS is due to 
ROS generation rather than to a reduced antioxidant 
response. Moreover, distinct antioxidant genes are 
induced at different time points and with different 
kinetics, probably due to the different substrate 
specificity of the encoded enzymes.
31
  
The principal source of ROS in eukaryotic cells are 
mitochondria. Denervation induces a rapid decrease in 
muscle mitochondrial content
32
 and an unbalance in 
mitochondrial ROS production.
33
 Moreover, numerous 
enzymes can also generate ROS, including NADPH 
oxidases, cyclooxygenases, lipoxygenases and NO 
synthases.
34
 We found an increase in the expression of 
 
 
Fig 3. Oxidative stress does not induce cellular damage in 
skeletal muscle following denervation. (A) Protein 
carbonyl content relative to contralateral muscles, 
seven days following denervation. n = 3. (B) 
Western blotting analyses for 4-HNE in contralateral 
and denervated muscles, 7 days following 
denervation. Gapdh was used as loading control. 
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Cybb, a subunit of NADPH oxidase, starting at three 
days after denervation, accompanied by a time-
dependent increase in NFκB activation. These findings 
suggest that NFκB might be responsible, at least in part, 
for ROS generation in denervated muscles. While there 
was a clear activation of the response to OS, no OS-
dependent damage was detected upon denervation, such 
as high levels of carbonyl groups and lipid peroxidation. 
Therefore, it seems likely that denervation triggers OS 
above the “harmful threshold” in skeletal muscle.20  
To test if OS play a direct role in the induction of 
muscle atrophy, we treated mice with antioxidant drugs, 
Trolox or Resveratrol, daily, for four weeks after 
denervation. Although both treatments reduced OS 
levels in skeletal muscle, the reduction of muscle mass 
was not affected by the drugs, indicating that 
neurogenic muscle atrophy does not depend on OS. 
Similar conclusions were drawn from several studies 
performed on murine models of disuse muscle atrophy, 
where Trolox treatment failed to protect against muscle 
mass loss.
35-37
 In conclusion, our study clarifies the 
kinetics of activation of OS response in denervated 
skeletal muscle. Despite the increase, OS does not lead 
to skeletal muscle damage and does not cause muscle 
atrophy in response to denervation. Delineation of the 
kinetics of activation of the molecular pathways 
triggered by the loss of motor neurons and their relative 
importance in the activation of the catabolic pathways, 
responsible of skeletal muscle atrophy, is a prerequisite 
for developing more appropriate drugs to treat 
neurogenic muscle atrophy. 
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Fig 4. Trolox does not prevent neurogenic muscle atrophy. (A) Western blotting analyses and (B) densitometry of Cybb of 
vehicle (-) or Trolox (TRX) treated mice, 7 days following denervation. Gapdh was used as loading control. Values 
represent mean ± SEM. n = 2-4; *p<0.05. (C) TA weight of vehicle or Trolox treated contralateral and denervated 
muscles, 14 and 28 days following denervation, relative to contralateral muscles of vehicle-treated mice. Values represent 
mean ± SEM. n = 3. **p<0.01. (D) Representative histology of vehicle or Trolox treated contralateral and denervated 
muscles, 14 and 28 days following denervation. Scale bar = 50μm. 
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